• PT
  • Pioneer Science receives visit from Jeffrey Glenn, a virologist from Stanford University

    Pioneer Science receives visit from Jeffrey Glenn, a virologist from Stanford University

    March, 14th 2024

    American scientist brings his expertise in molecular virology to the partnership with Pioneer Science and the D’Or Institute for Research and Education

    Respected gastroenterologist and molecular virologist from Stanford University, Jeffrey Glenn, embarks on a special visit to Brazil at the invitation of Pioneer Science (PS). During his stay in the country, from March 14 to 17, the scientist will visit Rio de Janeiro and São Paulo and will have the opportunity to interact with local scientists and explore the advances in research carried out in the laboratories of the D’Or Institute for Research and Education (IDOR) in both cities.

    As a research leader in molecular virology at Stanford, Glenn dedicates himself to searching for innovative antiviral therapies and studying virus mechanisms such as HDV (hepatitis D) and influenza. His visit to Pioneer Science aims to strengthen international collaboration ties, bringing his vast experience to contribute to scientific projects in Brazil.

    “The partnership between the Pioneer Science initiative, IDOR, and Stanford University, which began in 2022, is an important step in promoting excellence in scientific research and seeking innovative solutions to global health challenges,” says Jorge Moll Neto, physician and neuroscientist, and founder of PS. “Efforts in virology are of great importance, especially considering the current context, in which Brazil is facing a dengue epidemic.”

    In addition to Jeffrey Glenn’s presence, the visit also features the participation of Victor Geddes, a researcher and fellow at PS. With a trajectory marked by studies in genetics and molecular virology at the Federal University of Rio de Janeiro, Geddes is now pursuing his postdoctoral studies at Stanford under Glenn’s guidance, focusing on developing antivirals to combat arboviruses — viruses that are transmitted by insects, such as the dengue virus.

    In his most recent scientific collaboration, Geddes joined a group of scientists to analyze the possibility of oral biopsies of SARS-CoV-2 (coronavirus) supporting epidemiological surveillance. Access the article.


    See also